Cell Line with Stable Expression of Recombinant Human Chloride Channel, hCIC-4

The invention is a cell line (Human embryonic kidney 293) stably expressing a recombinant human chloride channel (hClC-4). The cells enable high throughput screening of compounds that modulate chloride channel activity.
Alfred GeorgeChristoph Fahlke
Licensing manager: 
Karen Rufus

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter